| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 6,481,000 | 7,443,000 | 8,032,000 | 8,340,000 | | Cost of Revenue | 85,000 | 454,000 | (3,537,000) | 3,537,000 | | | Gross Profit | 6,396,000 | 6,989,000 | 11,569,000 | 4,803,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,579,000 | 4,880,000 | 8,251,000 | 1,292,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,803,000 | 1,358,000 | 1,282,000 | 1,889,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,014,000 | 751,000 | 2,036,000 | 1,622,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,014,000 | 751,000 | 2,036,000 | 1,622,000 | | Interest Expense | 470,000 | 483,000 | 843,000 | 856,000 | | Income Before Tax | 544,000 | 268,000 | 1,193,000 | 766,000 | | Income Tax Expense | 101,000 | (38,000) | 257,000 | 111,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 443,000 | 306,000 | 936,000 | 655,000 | | | Non-recurring Events | | Discontinued Operations | (6,000) | (66,000) | (121,000) | (2,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 437,000 | 240,000 | 815,000 | 653,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $437,000 | $240,000 | $815,000 | $653,000 |
|
2.30% Nasdaq 
Income Statement
